POC Coagulation Diagnostics
Location: United States
Employees: 1-10
Total raised: $11.75M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.02.2026 | Series A | $11.75M | - |
Mentions in press and media 5
| Date | Title | Description |
| 27.02.2026 | Abram Scientific Secures $11.75M Series A | MENLO PARK, CA, Abram Scientific, a medical device company focused on advancing next-generation coagulation diagnostics, announced the closing of a $11.75 million Series A. >> Click here for more funding data on Abram Scientific >... |
| 26.02.2026 | Abram Scientific Fuels CoagCare with $11.75 Million Series A for Rapid Diagnostics | Abram Scientific secured $11.75 million in Series A funding. This investment propels CoagCare, their portable coagulation diagnostics platform. CoagCare rapidly identifies blood clotting and bleeding disorders. It aims to revolutionize pati... |
| 25.02.2026 | Abram Scientific Raises $11.75M in Series A Funding | Abram Scientific, a Menlo Park, CA-based medical device company, raised $11.75M in Series A funding. The round was led by Octapharma AG, with participation from existing and new investors affiliated with University of Colorado Anschutz. The... |
| 25.02.2026 | Abram Scientific: $11.75 Million Series A Raised For Portable Coagulation Diagnostics Platform CoagCare | Abram Scientific announced it has secured $11.75 million in Series A financing to accelerate development of its proprietary portable coagulation diagnostics platform, CoagCare. The round was led by global pharmaceutical company Octapharma A... |
| - | Abram Scientific | “Abram Scientific provides fast point of care (POC) coagulation diagnostics for hemostasis management and improved outcomes” |